Dynemicin A, Uncialamycin and Analogues
Isolation, Biological Activities and Syntheses
Publication Date: July 2016 Hardback 144 pp.
Enediynes are natural products with highly active cytotoxicity and antibacterial activity, and thus have significant potential in the development of anti-cancer treatments. However, they are not readily available and can degrade rapidly during isolation; one solution is to produce them using total synthesis.
Dynemicin A and uncialamycin are two such enediynes, with similar structures, for which total synthesis has been achieved. This book presents the isolation and preparation of these two compounds and their analogues through various synthesis strategies. Details of the structural elements essential to their anti-cancer activity are presented, with the objective of explaining and optimizing their biological activities and potential development as drugs.
1. Dynemicin A.
About the Authors
Daniel Best is a postdoctoral researcher at the University of Rennes 1 in France. He is currently developing the synthesis of uncialamycin analogues.
Mickael Jean is Associate Professor at the University of Rennes 1 in France. His research is concerned with the challenges of total synthesis of natural products and the development of anti-cancer medical chemistry programs.
Pierre van de Weghe is Professor in organic chemistry at the University of Rennes 1 in France. His work focuses on the total synthesis of natural products and analogues, as well as research into new components in anti-cancer activity